G9a/EHMT2 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F0379-20UL

Regular price €139,00 EUR
Regular price Sale price €139,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

G9a, also recognized as Euchromatic histone-lysine N-methyltransferase 2 (EHMT2), belongs to a family of histone lysine methyltransferases, featuring a conserved catalytic SET domain initially identified in Drosophila Su[var]3-9, Enhancer of zeste, and Trithorax proteins. In vitro, recombinant G9a exhibits the capability to mono-, di-, and tri-methylate histone H3 on Lys9 and Lys27. Depending on the literature source, EHMT2 may also be discussed as G9a/EHMT2 and EHMT2/G9A.

Reported cellular context includes chromosome and nucleus, which can matter when signal is compared across treatments or changing cell states. Following EHMT2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

EHMT2 is commonly interpreted in the context of epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between chromosome and nucleus across matched conditions
  • links between target behavior and transcriptional or chromatin-state changes
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EHMT2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EHMT2 reflect biology rather than handling. When interpreting EHMT2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep EHMT2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
EHMT2
Research Area:
Epigenetics
Application:
ChIP • IF • WB
Reactivity:
Human • Monkey • Mouse • Rat
Specificity:
G9a/EHMT2 Antibody [H23J7] detects endogenous levels of total G9a/EHMT2 protein (both the 165 kDa G9a-L and 140 kDa G9a-S isoforms). This antibody does not cross-react with other histone methyltransferases, including GLP.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
H23J7
UniProt:
Q96KQ7
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.